MarketBeat·2d ago
Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to WatchMedicare for All is back on Wall Street's radar. Democrats won control of both the House and Senate in the Nov. 3, 2026, midterm elections.
Aveanna Healthcare is demonstrating accelerating revenue growth, reaching 13.7% year-over-year in 2026Q2, driven by an acquisition-heavy model that has expanded its scale.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 13, 2026 | $0.22+30.7% vs $0.17 | $670M+5.0% vs $639M |
Q2 2026 May 14, 2026 | $0.18+38.5% vs $0.13 | $648M+5.7% vs $613M |
Q2 2026 Mar 19, 2026 | $0.17+10.5% vs $0.15 | $662M+3.0% vs $643M |
Q4 2025 Nov 6, 2025 | $0.15+87.5% vs $0.08 | $622M-4.2% vs $649M |
Medicare for All is back on Wall Street's radar. Democrats won control of both the House and Senate in the Nov. 3, 2026, midterm elections.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
ATLANTA, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its third quarter results before the market open on Thursday, November 12, 2026, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day.
Here is how Aveanna Healthcare (AVAH) and Elanco Animal Health Incorporated (ELAN) have performed compared to their sector so far this year.
Benchmark AVAH against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Aveanna Healthcare Holdings Inc. (AVAH)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $13.25 | $2.89B | 10.84 | 20.19% | 10.56% | 150.2% | — | |
| $36.36 | $1.26B | 36.88 | 36.31% | 3.05% | 9.04% | — | |
| $124.31 | $2.32B | 20.79 | 23.21% | 7.39% | 9.81% | — | |
| $24.28 | $1.67B | 16.06 | 7.08% | 5.58% | 20.22% | — | |
| $181.08 | $10.55B | 26.91 | 18.72% | 7.03% | 16.61% | 0.14% | |
| $65.50 | $3.44B | 9.37 | 2.36% | 7.07% | 21.72% | 1.81% |
Aveanna Healthcare Holdings Inc. (AVAH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Aveanna Healthcare Holdings Inc. (AVAH) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 24, 2026·SEC
Aug 13, 2026·SEC
Aug 13, 2026·SEC
Get notified when AVAH posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Aveanna Healthcare Holdings Inc. (AVAH) stock FAQ — growth, dividends, profitability & financials explained
Aveanna Healthcare Holdings Inc. (AVAH) reported $2.60B in revenue over the trailing twelve months. Revenue was $2.43B in fiscal year 2025. That is 94% more than the $1.25B of fiscal year 2018.
Aveanna Healthcare Holdings Inc. (AVAH) grew revenue by 19.5% over the trailing twelve months, compared with the twelve months before.
Yes. Aveanna Healthcare Holdings Inc. (AVAH) earned $274.8M in net income over the trailing twelve months (a 10.6% net margin).
Aveanna Healthcare Holdings Inc. (AVAH) had a return on equity (ROE) of 150.2% over the trailing twelve months. That is well above the market's typical 10-15%.
Aveanna Healthcare Holdings Inc. (AVAH) generated $165.8M in free cash flow over the trailing twelve months.
